The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder (BCPP BIODA)
BC Psychosis Program Biobank and Database for Investigating Genetic Polymorphisms of Brain-derived Neurotrophic Factor and Catechol-o-methyl Transferase and Their Associations With Psychosis Disorder
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Delrae Fawcett, M.Sc.
- Phone Number: 6115 604-875-2000
- Email: delrae.fawcett@ubc.ca
Study Contact Backup
- Name: Heidi Boyda, Ph.D.
- Phone Number: 6484 604-875-2000
- Email: heidi.boyda@ubc.ca
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 2A1
- Recruiting
- University of British Columbia Hospital - BC Psychosis Program
-
Contact:
- Delrae Fawcett, M.Sc.
- Phone Number: 6115 604-875-2000
- Email: delrae.fawcett@ubc.ca
-
Contact:
- Heidi N Boyda, Ph.D.
- Phone Number: 6484 604-875-2000
- Email: heidi.boyda@ubc.ca
-
Principal Investigator:
- Alasdair M Barr, Ph.D.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Admission to BCPP.
- Has provided written informed consent.
Exclusion Criteria:
- None.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Participants admitted to BCPP
Blood or saliva samples will be collected from participants for whole genomic/transcriptomic sequencing
|
Participant will receive one blood draw whereby two samples will be extracted.
If the participant wishes to participate in the study but is fearful of needles, they may be given the option to provide a saliva sample.
A retrospective medical chart review will be performed after participant is discharged from BCPP in order to obtain a full phenotype.
Genotyping of BDNF and COMT will be performed.
Protein levels of BDNF will be determined.
The remaining blood or saliva samples will be stored over the long-term in a biorepository at the BC Mental Health and Addictions Research Institute.
A retrospective medical chart review will be completed after the participant is discharged.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Creation of biorepository of blood samples for future genetic, proteonomic and pharmacogenomic studies.
Time Frame: One visit during participant's stay at BCPP, an expected average of 6 months
|
A biobank of stored samples will be used to determine the genetic variability in psychosis disorder.
|
One visit during participant's stay at BCPP, an expected average of 6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of single-nucleotide polymorphisms (SNPs) in the BDNF and COMT genes
Time Frame: One visit during participant's stay at BCPP, an expected average of 6 months
|
We will determine if specific genetic variants in BDNF and COMT genes are associated with psychosis disorder severity, symptomology and resolution.
|
One visit during participant's stay at BCPP, an expected average of 6 months
|
|
Medical Chart Review
Time Frame: One visit during participant's stay at BCPP, an expected average of 6 months
|
A medical chart review will be done on hard-copy medical charts at BCPP.
|
One visit during participant's stay at BCPP, an expected average of 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Alasdair M Barr, Ph.D., University of British Columbia
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- H14-01136
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.